Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


Articles published in Am J Ophthalmol

Retrieve available abstracts of 35 articles:
HTML format
Text format



Single Articles


    August 2018
  1. CAI L, Paez-Escamilla M, Walter SD, Tarlan B, et al
    Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma.
    Am J Ophthalmol. 2018 Aug 6. pii: S0002-9394(18)30438.
    PubMed     Text format     Abstract available


  2. DEMIRCI H, Niziol LM, Ozkurt Z, Slimani N, et al
    Do Largest Basal Tumor Diameter and the American Joint Commission Cancer Staging Influence Prognostication by Gene Expression Profiling in Choroidal Melanoma?
    Am J Ophthalmol. 2018 Aug 3. pii: S0002-9394(18)30426.
    PubMed     Text format     Abstract available


    April 2018
  3. SEIBEL I, Riechardt AI, Erb-Eigner K, Boker A, et al
    Proton beam irradiation: a safe procedure in post-equatorial extraocular extension from uveal melanoma.
    Am J Ophthalmol. 2018 Apr 12. pii: S0002-9394(18)30166.
    PubMed     Text format     Abstract available


    March 2018
  4. DAMATO B, Hope-Stone L, Cooper B, Brown S, et al
    Patient-Reported Outcomes and Quality of Life after Treatment of Choroidal Melanoma: a Comparison of Enucleation vs Radiotherapy in 1596 patients.
    Am J Ophthalmol. 2018 Mar 16. pii: S0002-9394(18)30113.
    PubMed     Text format     Abstract available


  5. GLASGOW BJ, McCannel TA
    Correlation of immunocytochemistry of BRCA1-associated protein 1 (BAP1) with other prognostic markers in uveal melanoma.
    Am J Ophthalmol. 2018 Mar 9. pii: S0002-9394(18)30103.
    PubMed     Text format     Abstract available


    January 2018
  6. MAHESHWARI A, Finger PT
    A 12-Year Study of Slotted Palladium-103 Plaque Radiation Therapy for Choroidal Melanoma: Near, Touching, or Surrounding the Optic Nerve.
    Am J Ophthalmol. 2018 Jan 31. pii: S0002-9394(18)30032.
    PubMed     Text format     Abstract available


    November 2017
  7. OELLERS P, Mowery YM, Perez BA, Stinnett S, et al
    Efficacy and safety of low dose iodine plaque brachytherapy for juxtapapillary choroidal melanoma.
    Am J Ophthalmol. 2017 Nov 30. pii: S0002-9394(17)30486.
    PubMed     Text format     Abstract available


    July 2017
  8. FINGER PT, Sauerwein WAG
    Local Failure After Episcleral Brachytherapy for Posterior Uveal Melanoma: Patterns, Risk Factors, and Management.
    Am J Ophthalmol. 2017 Jul 27. pii: S0002-9394(17)30283.
    PubMed     Text format    


  9. BELLERIVE C, Aziz HA, Bena J, Wilkinson A, et al
    Local Failure After Episcleral Brachytherapy for Posterior Uveal Melanoma: Patterns, Risk Factors, and Management.
    Am J Ophthalmol. 2017 Jul 26. pii: S0002-9394(17)30284.
    PubMed     Text format    


    June 2017
  10. FABIAN ID, Thaung C, AlHarby L, Sisley K, et al
    Late Solitary Extraocular Recurrence from Previously Resected Iris Melanoma.
    Am J Ophthalmol. 2017 Jun 30. pii: S0002-9394(17)30279.
    PubMed     Text format     Abstract available


  11. SELLAM A, Coscas F, Lumbroso-Le Rouic L, Dendale R, et al
    Optical Coherence Tomography-Angiography of Macular Features after Proton Beam Radiotherapy for Small Choroidal Melanoma.
    Am J Ophthalmol. 2017 Jun 21. pii: S0002-9394(17)30251.
    PubMed     Text format     Abstract available


  12. SEIBEL I, Riechardt AI, Heufelder J, Cordini D, et al
    Adjuvant Ab Interno Tumor Treatment After Proton Beam Irradiation.
    Am J Ophthalmol. 2017;178:94-100.
    PubMed     Text format     Abstract available


    May 2017
  13. SANCHEZ-TABERNERO S, Garcia-Alvarez C, Munoz-Moreno MF, Diezhandino P, et al
    Pattern of Local Recurrence After I-125 Episcleral Brachytherapy for Uveal Melanoma in a Spanish Referral Ocular Oncology Unit.
    Am J Ophthalmol. 2017 May 29. pii: S0002-9394(17)30221.
    PubMed     Text format     Abstract available


    February 2017
  14. BELLERIVE C, Aziz HA, Bena J, Wilkinson A, et al
    Local Failure after Episcleral Brachytherapy for Posterior Uveal Melanoma: Patterns, Risk Factors and Management.
    Am J Ophthalmol. 2017 Feb 2. pii: S0002-9394(17)30048.
    PubMed     Text format     Abstract available


  15. ARES WJ, Tonetti D, Yu JY, Monaco EA, et al
    Gamma Knife Radiosurgery for Uveal Metastases: Report of Three Cases and a Review of the Literature.
    Am J Ophthalmol. 2017;174:169-174.
    PubMed     Text format     Abstract available


    December 2016
  16. KING B, Morales-Tirado VM, Wynn HG, Gao BT, et al
    Repeat Episcleral Plaque Brachytherapy: Clinical Outcomes in Patients Treated for Locally Recurrent Posterior Uveal Melanoma.
    Am J Ophthalmol. 2016 Dec 31. pii: S0002-9394(16)30629.
    PubMed     Text format     Abstract available


  17. SNYDER ME, Osher RH, Wladecki TM, Perez MA, et al
    Results in combined cataract surgery with prosthetic iris implantation in patients with previous iridocyclectomy for iris melanoma.
    Am J Ophthalmol. 2016 Dec 6. pii: S0002-9394(16)30588.
    PubMed     Text format     Abstract available


    November 2016
  18. KIM RS, Chevez-Barrios P, Bretana ME, Wong TP, et al
    Histopathologic Analysis of Trans-vitreal Fine Needle Aspiration Biopsy Needle Tracts for Uveal Melanoma.
    Am J Ophthalmol. 2016 Nov 3. pii: S0002-9394(16)30532.
    PubMed     Text format     Abstract available


    June 2016
  19. KIVELA TT, Piperno-Neumann S, Desjardins L, Schmittel A, et al
    Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology Group.
    Am J Ophthalmol. 2016 Jun 10. pii: S0002-9394(16)30266.
    PubMed     Text format     Abstract available


  20. IOVIENO A, Longo C, De Luca M, Piana S, et al
    Fluorescence confocal microscopy for ex vivo diagnosis of conjunctival tumors: a pilot study.
    Am J Ophthalmol. 2016 Jun 10. pii: S0002-9394(16)30265.
    PubMed     Text format     Abstract available


    May 2016
  21. SEIBEL I, Hager A, Riechardt AI, Davids AM, et al
    Antiangiogenic or corticosteroid treatment in patients with radiation maculopathy after proton beam therapy for uveal melanoma: Anti-VEGFs versus corticosteroids for radiation maculopathy.
    Am J Ophthalmol. 2016 May 6. pii: S0002-9394(16)30199.
    PubMed     Text format     Abstract available


    April 2016
  22. CAMINAL JM, Mejia K, Arias L, Masuet-Aumatell C, et al
    Tumor volumes in choroidal melanoma: agreement between three-dimensional ultrasound and two mathematical models.
    Am J Ophthalmol. 2016 Apr 8. pii: S0002-9394(16)30150.
    PubMed     Text format     Abstract available


    February 2016
  23. BENSOUSSAN E, Thariat J, Maschi C, Delas J, et al
    Outcomes after proton beam therapy for large choroidal melanomas in 492 patients.
    Am J Ophthalmol. 2016 Feb 29. pii: S0002-9394(16)30077.
    PubMed     Text format     Abstract available


  24. LAINS I, Bartosch C, Mondim V, Healy B, et al
    Second primary neoplasms in patients with uveal melanoma: a SEER database analysis.
    Am J Ophthalmol. 2016 Feb 29. pii: S0002-9394(16)30072.
    PubMed     Text format     Abstract available


  25. JAKOBIEC FA
    Naming the Precursors of Conjunctival Melanoma.
    Am J Ophthalmol. 2016 Feb 4. pii: S0002-9394(15)30047.
    PubMed     Text format    


    January 2016
  26. LEE JH, Lee SC, Cho A, Keum KC, et al
    Association Between Choroidal Thickness and Metabolic Activity on Positron Emission Tomography in Eyes With Choroidal Melanoma.
    Am J Ophthalmol. 2016 Jan 14. pii: S0002-9394(16)30003.
    PubMed     Text format    


  27. KAYA A
    Association Between Choroidal Thickness and Metabolic Activity on Positron Emission Tomography in Eyes With Choroidal Melanoma.
    Am J Ophthalmol. 2016 Jan 14. pii: S0002-9394(16)30005.
    PubMed     Text format    


    December 2015
  28. FOLBERG R
    Naming the Precursors of Conjunctival Melanoma.
    Am J Ophthalmol. 2015 Dec 19. pii: S0002-9394(15)30012.
    PubMed     Text format    


    November 2015
  29. LOKDARSHI G, Vuthaluru S, Pushker N, Kumar R, et al
    Sentinel Lymph Node Biopsy in Malignant Eyelid Tumor: Hybrid Single Photon Emission Computed Tomography/Computed Tomography and Dual Dye Technique.
    Am J Ophthalmol. 2015 Nov 20. pii: S0002-9394(15)00679.
    PubMed     Text format    


  30. CORREA ZM, Augsburger JJ
    Independent Prognostic Significance of Gene Expression Profile Class and Largest Basal Diameter of Posterior Uveal Melanomas.
    Am J Ophthalmol. 2015 Nov 17. pii: S0002-9394(15)00707.
    PubMed     Text format     Abstract available


  31. SELLAM A, Desjardins L, Barnhill R, Plancher C, et al
    Fine Needle Aspiration Biopsy in Uveal Melanoma: Technique, Complications, and Outcomes.
    Am J Ophthalmol. 2015 Nov 7. pii: S0002-9394(15)00686.
    PubMed     Text format     Abstract available


    September 2015
  32. FABIAN ID, Tomkins-Netzer O, Stoker I, Arora AK, et al
    Secondary Enucleations for Uveal Melanoma: A 7-Year Retrospective Analysis.
    Am J Ophthalmol. 2015 Sep 3. pii: S0002-9394(15)00541.
    PubMed     Text format     Abstract available


  33. LEE JH, Lee SC, Cho A, Keum KC, et al
    Association between Choroidal Thickness and Metabolic Activity on Positron Emission Tomography in Eyes with Choroidal Melanoma.
    Am J Ophthalmol. 2015 Sep 2. pii: S0002-9394(15)00538.
    PubMed     Text format     Abstract available


    July 2015
  34. NIRO A, Strippoli S, Alessio G, Sborgia L, et al
    Ocular toxicity in metastatic melanoma patients treated with Mitogen activated protein kinase inhibitors: a case series.
    Am J Ophthalmol. 2015 Jul 28. pii: S0002-9394(15)00459.
    PubMed     Text format     Abstract available


    June 2015
  35. SEIBEL I, Cordini D, Rehak M, Hager A, et al
    Local recurrence after primary proton beam therapy in uveal melanoma: Risk factors, retreatment approaches and outcome.
    Am J Ophthalmol. 2015 Jun 29. pii: S0002-9394(15)00372.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: